The United States Smoking Cessation & Nicotine De-Addiction Product Market size was estimated at USD 2,882.28 million in 2022, USD 3,162.65 million in 2023 and is projected to grow at a CAGR of 9.72% to reach USD 6,055.72 million by 2030.
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Smoking Cessation & Nicotine De-Addiction Product Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
4. What is the competitive strategic window for opportunities in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
5. What are the technology trends and regulatory frameworks in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
6. What is the market share of the leading vendors in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
7. What modes and strategic moves are considered suitable for entering the United States Smoking Cessation & Nicotine De-Addiction Product Market?
Cumulative Impact of COVID-19:
COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Smoking Cessation & Nicotine De-Addiction Product Market.Cumulative Impact of Russia-Ukraine Conflict:
The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Smoking Cessation & Nicotine De-Addiction Product Market considering the current update on the conflict and its global responses.Cumulative Impact of High Inflation:
The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Smoking Cessation & Nicotine De-Addiction Product Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.Market Segmentation & Coverage:
The report on the United States Smoking Cessation & Nicotine De-Addiction Product Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Smoking Cessation & Nicotine De-Addiction Product Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:- Based on Product, the market is studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
- Based on Distribution, the market is studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
- Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Smoking Cessation & Nicotine De-Addiction Product Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Smoking Cessation & Nicotine De-Addiction Product Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Smoking Cessation & Nicotine De-Addiction Product Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Smoking Cessation & Nicotine De-Addiction Product Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Smoking Cessation & Nicotine De-Addiction Product Market, including 22nd Century Group, Inc., Alkalon A/S, Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Dr. Reddy’s Laboratories Limited, GlaxoSmithKline PLC, Imperial Tobacco Company of India Limited, Itaconix, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs, Inc., NJOY, LLC, Novartis International AG, Perrigo Company PLC, Pfizer Inc., Philip Morris International Inc., Pierre Fabre S.A., Rusan Pharma Ltd., and Takeda Pharmaceutical Co., Ltd..The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the United States Smoking Cessation & Nicotine De-Addiction Product Market?2. What are the inhibiting factors and impact of COVID-19 shaping the United States Smoking Cessation & Nicotine De-Addiction Product Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
4. What is the competitive strategic window for opportunities in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
5. What are the technology trends and regulatory frameworks in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
6. What is the market share of the leading vendors in the United States Smoking Cessation & Nicotine De-Addiction Product Market?
7. What modes and strategic moves are considered suitable for entering the United States Smoking Cessation & Nicotine De-Addiction Product Market?
Frequently Asked Questions about the U.S. Smoking Cessation & Nicotine De-Addiction Product Market
What is the estimated value of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?
What is the growth rate of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?
What is the forecasted size of the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?
Who are the key companies in the U.S. Smoking Cessation & Nicotine De-Addiction Product Market?
Report Attribute | Details |
---|---|
No. of Pages | 147 |
Published | January 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2882.28 Million |
Forecasted Market Value ( USD | $ 6055.72 Million |
Compound Annual Growth Rate | 9.7% |
Regions Covered | United States |
No. of Companies Mentioned | 20 |
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization
6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product
6.1. Introduction
6.2. Drug Therapy
6.3.1. Chantix (Varenicline)
6.3.2. Zyban (Bupropion)
6.3. E-Cigarettes
6.4. Nicotine Inhalers
6.5. Nicotine Replacement Therapies
6.6.1. Nicotine Gums
6.6.2. Nicotine Lozenges
6.6.3. Nicotine Sprays
6.6.4. Nicotine Transdermal Patches
6.6. Nicotine Sublingual Tablets
7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution
7.1. Introduction
7.2. Drug Store
7.3. Hospital Pharmacies
7.4. Online Pharmacies
7.5. Retail Pharmacies
8. California Smoking Cessation & Nicotine De-Addiction Product Market
8.1. Introduction
9. Florida Smoking Cessation & Nicotine De-Addiction Product Market
9.1. Introduction
10. Illinois Smoking Cessation & Nicotine De-Addiction Product Market
10.1. Introduction
11. New York Smoking Cessation & Nicotine De-Addiction Product Market
11.1. Introduction
12. Ohio Smoking Cessation & Nicotine De-Addiction Product Market
12.1. Introduction
13. Pennsylvania Smoking Cessation & Nicotine De-Addiction Product Market
13.1. Introduction
14. Texas Smoking Cessation & Nicotine De-Addiction Product Market
14.1. Introduction
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Product Portfolio Analysis, By Key Player
15.5. Competitive Scenario
15.5.1. Merger & Acquisition
15.5.2. Agreement, Collaboration, & Partnership
15.5.3. New Product Launch & Enhancement
15.5.4. Investment & Funding
15.5.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. 22nd Century Group, Inc.
16.2. Alkalon A/S
16.3. Axsome Therapeutics, Inc.
16.4. British American Tobacco PLC
16.5. Cipla Ltd.
16.6. Dr. Reddy’s Laboratories Limited
16.7. GlaxoSmithKline PLC
16.8. Imperial Tobacco Company of India Limited
16.9. Itaconix
16.10. Japan Tobacco Inc.
16.11. Johnson & Johnson
16.12. JUUL Labs, Inc.
16.13. NJOY, LLC
16.14. Novartis International AG
16.15. Perrigo Company PLC
16.16. Pfizer Inc.
16.17. Philip Morris International Inc.
16.18. Pierre Fabre S.A.
16.19. Rusan Pharma Ltd.
16.20. Takeda Pharmaceutical Co., Ltd.
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET DYNAMICS
FIGURE 8. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 24. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION, 2030
FIGURE 26. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 30. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 38. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 39. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 38. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. CALIFORNIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 40. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 41. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. FLORIDA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ILLINOIS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 46. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 47. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. NEW YORK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 50. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. OHIO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 52. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. PENNSYLVANIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 55. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 56. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. TEXAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 59. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 60. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 61. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RANKING, BY KEY PLAYER, 2022
TABLE 62. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 63. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 64. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET MERGER & ACQUISITION
TABLE 65. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 66. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 67. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET INVESTMENT & FUNDING
TABLE 68. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 69. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET: LICENSE & PRICING
Companies Mentioned
- 22nd Century Group, Inc.
- Alkalon A/S
- Axsome Therapeutics, Inc.
- British American Tobacco PLC
- Cipla Ltd.
- Dr. Reddy’s Laboratories Limited
- GlaxoSmithKline PLC
- Imperial Tobacco Company of India Limited
- Itaconix
- Japan Tobacco Inc.
- Johnson & Johnson
- JUUL Labs, Inc.
- NJOY, LLC
- Novartis International AG
- Perrigo Company PLC
- Pfizer Inc.
- Philip Morris International Inc.
- Pierre Fabre S.A.
- Rusan Pharma Ltd.
- Takeda Pharmaceutical Co., Ltd.
Methodology
LOADING...